Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept—Targeted Drug Delivery with Antibody–Drug Conjugates for Cancers-Reference-Cited by-同舟云学术

Trends in Translational Medicine and Drug Targeting and Delivery: New Insights on an Old Concept—Targeted Drug Delivery with Antibody–Drug Conjugates for Cancers

Published:2014-01 Issue:1 Volume:103 Page:71-77
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Rodney J.Y.,Chien Jenny

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference21 articles.

1. Zur Kenntnis der Antitoxinwirkung;Ehrlich;Fortschritte der Medizin,1897

2. Continuous cultures of fused cells secreting antibody of predefined specificity;Kohler;Nature,1975

3. Drug delivery trends in clinical trials and translational medicine: Growth in biologic molecule development and impact on rheumatoid arthritis, Crohn's disease, and colitis;Ho;J Pharm Sci,2012

4. Drug delivery trends in clinical trials and translational medicine;Chien;J Pharm Sci,2008

5. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma;Witzig;J Clin Oncol,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The chemistry of heterocycles in the 21st century;Russian Chemical Reviews;2024-07

2. Biologic from mammalian and non-mammalian cell lines;Advanced Biologic Drugs and Manufacturing Process;2024

3. Recombinant Human Clusterin Seals Damage to the Ocular Surface Barrier in a Mouse Model of Ophthalmic Preservative-Induced Epitheliopathy;International Journal of Molecular Sciences;2023-01-04

4. Challenging Post-translational Modifications in the Cell-free Protein Synthesis System;Synthetic Biology and Engineering;2023

5. Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response;Pharmacology & Therapeutics;2022-08